What You Should Know:
- Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study.
- The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms.
Challenges Diagnosing Parkinson’s
Read More
Digital Pathology
Tempus Launches Pathology-Driven AI Platform
What You Should Know:
- Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide.
- With access to over 50 petabytes of de-identified multimodal data, Tempus is developing AI models with the aim to identify patients who would
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Verily & Lumea Partner to Leverage AI in Prostate Cancer Diagnoses
What You Should Know:
- Verily and Lumea today announced a strategic partnership to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.
- Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health.
Partnership Goals
The Verily-Lumea collaboration will utilize Lumea’s digital pathology platform
Read More
Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology
What You Should Know:
- Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers.
- Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon enterprise imaging solution with Proscia’s Concentriq Dx digital pathology platform.
Read More
Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology
What You Should Know:
- Proscia, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale.
- The cooperation agreement increases the availability of the companies' best-of-breed, unified solution that combines Proscia's Concentriq® platform and Hamamatsu's NanoZoomer® series of whole slide scanners to deliver
Read More
Why Digital Pathology Platform Adoption Will Fail Without Interoperability
The global pandemic has cast a spotlight on the impact of digital transformation in healthcare. From ensuring access to care with telemedicine to accelerating vaccine development, technology has rapidly unlocked new sources of value for patients, providers, and researchers alike. While much of this has played out before our very eyes, other advancements have been less visible but equally as significant.
Consider the rise of digital pathology. Pathology sits at the core of disease diagnosis;
Read More
PathologyWatch Lands $25M for Digital Dermpath Lab Platform
What You Should Know:
- Digital lab and pathology platform PathologyWatch, today announced $25 million in Series B funding with participation from Ceros Capital Markets, Rock Creek Capital,Springtide Capital, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group, and existing investors.
- AI in diagnostic services grew by 80% in 2020, largely in response to the COVID-19 pandemic, which also brought to our attention the need for more equitable and accessible healthcare. With
Read More
HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps
What You Should Know:
- Ibex Medical Analytics, the pioneer in AI-based cancer diagnostics, today announced that it has signed a deal with Roche, the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to enable pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology,
Read More
Philips, Ibex Medical Analytics Partner on AI-Powered Digital Pathology Adoption
What You Should Know:
- Philips and Ibex Medical Analytics announced a strategic partnership to globally commercialize clinically proven, AI-powered digital pathology solutions. The collaboration further cements Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis.
- The trend towards centralized pathology labs, the global shortage of trained pathologists, and increasing demands on histopathology posed by the growing number of cancer
Read More
